Strides Pharma reiterated its guidance that US sales will reach $400 million by financial year 2028. Its margins also expanded from the same quarter last year. The stock has surged in response.
The cumulative addressable market for the acquired portfolio was $4.7 billion as of May 2021 The approved medicine slows down HIV spread and prescribed along with other medications to treat adults and ...
The word ‘stride’ can seem quite confusing in the context of running. First, there’s stride length, which is an aspect of running form. Stride length refers to the distance covered between the spot ...
Company will evaluate data from patients enrolled to date and share updated plans for azelaprag in Q1 2025 In parallel to evaluating azelaprag, Company will continue to advance earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results